Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/100062

Beta release

Statistics of Results from a phase III trial (GRID) evaluating regorafenib in metastatic gastrointestinal stromal tumour (GIST): Subgroup analysis of outcomes based on pretreatment characteristics
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0700
2024-0800
2024-0900